Afamelanotide

Afamelanotide is a synthetic analog of alpha-MSH that acts as a potent MC1R agonist, approved for treating erythropoietic protoporphyria. It is studied for its ability to induce melanin production, offering photoprotection and potential tanning effects.

In the literature, Afamelanotide appears most often in work focused on tanning, skin health and antioxidant. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Afamelanotide is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.